Northern Trust Corp decreased its position in Hill-Rom Holdings Inc (NYSE:HRC) by 14.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 628,645 shares of the medical technology company’s stock after selling 102,563 shares during the period. Northern Trust Corp owned about 0.95% of Hill-Rom Holdings worth $50,046,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Canada Pension Plan Investment Board grew its holdings in Hill-Rom Holdings by 42.7% in the second quarter. Canada Pension Plan Investment Board now owns 16,700 shares of the medical technology company’s stock valued at $1,329,000 after purchasing an additional 5,000 shares during the last quarter. American Century Companies Inc. grew its holdings in Hill-Rom Holdings by 1,191.1% in the second quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after purchasing an additional 101,811 shares during the last quarter. Prudential Financial Inc. grew its holdings in Hill-Rom Holdings by 6.6% in the second quarter. Prudential Financial Inc. now owns 545,786 shares of the medical technology company’s stock valued at $43,449,000 after purchasing an additional 33,714 shares during the last quarter. Brookstone Capital Management acquired a new stake in Hill-Rom Holdings in the second quarter valued at $289,000. Finally, Chase Investment Counsel Corp acquired a new stake in Hill-Rom Holdings in the second quarter valued at $675,000. 82.31% of the stock is currently owned by institutional investors.
Shares of Hill-Rom Holdings Inc (HRC) opened at 77.38 on Friday. The firm has a 50-day moving average price of $75.32 and a 200 day moving average price of $75.89. The firm has a market cap of $5.10 billion, a price-to-earnings ratio of 45.09 and a beta of 1.19. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company had revenue of $689.10 million for the quarter, compared to the consensus estimate of $695.50 million. During the same quarter in the previous year, the business earned $0.81 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, equities research analysts anticipate that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 29th. Stockholders of record on Friday, September 15th were paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend was Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.
In other news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the sale, the senior vice president now directly owns 16,701 shares in the company, valued at $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
Several research firms have weighed in on HRC. Zacks Investment Research raised Hill-Rom Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, September 26th. BidaskClub lowered Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Cantor Fitzgerald began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price on the stock. Stifel Nicolaus reissued a “buy” rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Finally, Needham & Company LLC began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “buy” rating and a $95.00 target price on the stock. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $87.80.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.